CRL
Price
$206.54
Change
-$9.40 (-4.35%)
Updated
Nov 13 closing price
90 days until earnings call
HAE
Price
$91.78
Change
-$1.60 (-1.71%)
Updated
Nov 13 closing price
89 days until earnings call
Ad is loading...

CRL vs HAE

Header iconCRL vs HAE Comparison
Open Charts CRL vs HAEBanner chart's image
Charles River Laboratories International
Price$206.54
Change-$9.40 (-4.35%)
Volume$981.96K
CapitalizationN/A
Haemonetics
Price$91.78
Change-$1.60 (-1.71%)
Volume$778.16K
CapitalizationN/A
CRL vs HAE Comparison Chart
Loading...
CRL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HAE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CRL vs. HAE commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a StrongSell and HAE is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (CRL: $206.54 vs. HAE: $91.78)
Brand notoriety: CRL and HAE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 134% vs. HAE: 121%
Market capitalization -- CRL: $13.96B vs. HAE: $4.33B
CRL [@Medical Specialties] is valued at $13.96B. HAE’s [@Medical Specialties] market capitalization is $4.33B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 0 FA rating(s) are green whileHAE’s FA Score has 0 green FA rating(s).

  • CRL’s FA Score: 0 green, 5 red.
  • HAE’s FA Score: 0 green, 5 red.
According to our system of comparison, CRL is a better buy in the long-term than HAE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 5 TA indicator(s) are bullish while HAE’s TA Score has 5 bullish TA indicator(s).

  • CRL’s TA Score: 5 bullish, 5 bearish.
  • HAE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CRL is a better buy in the short-term than HAE.

Price Growth

CRL (@Medical Specialties) experienced а -3.58% price change this week, while HAE (@Medical Specialties) price change was +17.43% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.86%. For the same industry, the average monthly price growth was +1.31%, and the average quarterly price growth was -3.19%.

Reported Earning Dates

CRL is expected to report earnings on Feb 12, 2025.

HAE is expected to report earnings on Feb 11, 2025.

Industries' Descriptions

@Medical Specialties (-0.86% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($14B) has a higher market cap than HAE($4.34B). HAE has higher P/E ratio than CRL: HAE (34.47) vs CRL (29.15). HAE YTD gains are higher at: 7.332 vs. CRL (-12.631). CRL has higher annual earnings (EBITDA): 1.03B vs. HAE (264M). CRL has more cash in the bank: 277M vs. HAE (194M). HAE has less debt than CRL: HAE (871M) vs CRL (3.07B). CRL has higher revenues than HAE: CRL (4.13B) vs HAE (1.27B).
CRLHAECRL / HAE
Capitalization14B4.34B323%
EBITDA1.03B264M391%
Gain YTD-12.6317.332-172%
P/E Ratio29.1534.4785%
Revenue4.13B1.27B325%
Total Cash277M194M143%
Total Debt3.07B871M352%
FUNDAMENTALS RATINGS
CRL vs HAE: Fundamental Ratings
CRL
HAE
OUTLOOK RATING
1..100
923
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
70100
SMR RATING
1..100
6160
PRICE GROWTH RATING
1..100
4642
P/E GROWTH RATING
1..100
3461
SEASONALITY SCORE
1..100
46n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HAE's Valuation (75) in the Medical Specialties industry is in the same range as CRL (77) in the Miscellaneous Commercial Services industry. This means that HAE’s stock grew similarly to CRL’s over the last 12 months.

CRL's Profit vs Risk Rating (70) in the Miscellaneous Commercial Services industry is in the same range as HAE (100) in the Medical Specialties industry. This means that CRL’s stock grew similarly to HAE’s over the last 12 months.

HAE's SMR Rating (60) in the Medical Specialties industry is in the same range as CRL (61) in the Miscellaneous Commercial Services industry. This means that HAE’s stock grew similarly to CRL’s over the last 12 months.

HAE's Price Growth Rating (42) in the Medical Specialties industry is in the same range as CRL (46) in the Miscellaneous Commercial Services industry. This means that HAE’s stock grew similarly to CRL’s over the last 12 months.

CRL's P/E Growth Rating (34) in the Miscellaneous Commercial Services industry is in the same range as HAE (61) in the Medical Specialties industry. This means that CRL’s stock grew similarly to HAE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLHAE
RSI
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
65%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 3 days ago
66%
Declines
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 15 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
62%
View a ticker or compare two or three
Ad is loading...
CRL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HAE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBTG22.790.03
+0.11%
iShares iBonds Dec 2026 Term Tr ETF
HYGH86.770.02
+0.02%
iShares Interest Rate Hdg Hi Yld Bd ETF
GRNB23.91-0.01
-0.03%
VanEck Green Bond ETF
ROAM23.89-0.08
-0.31%
Hartford Multifactor Emerging Mkts ETF
PFH19.92-0.16
-0.80%
Prudential Financial

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-4.35%
IQV - CRL
73%
Closely correlated
-0.96%
AZTA - CRL
58%
Loosely correlated
-3.24%
CTKB - CRL
58%
Loosely correlated
-3.69%
RGEN - CRL
56%
Loosely correlated
+1.24%
TMO - CRL
53%
Loosely correlated
+0.21%
More